Core Viewpoint - The financial performance of Chuanheng Co., Ltd. shows significant growth in revenue and net profit, indicating a strong operational capacity and market demand for its phosphate products [2]. Group 1: Financial Performance - For the period from January to September 2025, Chuanheng Co., Ltd. achieved a revenue of 5.804 billion yuan, representing a year-on-year increase of 46.08% [2]. - The net profit attributable to shareholders for the same period was 965 million yuan, reflecting a year-on-year growth of 43.50% [2]. - Cumulative cash dividends since the company's A-share listing amount to 2.133 billion yuan, with 1.729 billion yuan distributed over the past three years [3]. Group 2: Shareholder and Market Activity - As of January 9, 2025, the number of shareholders for Chuanheng Co., Ltd. was 29,300, a decrease of 2.14% from the previous period [2]. - The average number of circulating shares per shareholder increased by 2.19% to 20,364 shares [2]. - The financing balance for Chuanheng Co., Ltd. reached 476 million yuan, accounting for 2.06% of its market capitalization, which is above the 90th percentile of the past year [1]. Group 3: Business Operations - Chuanheng Co., Ltd. specializes in the production and sale of phosphate and phosphate-related products, with the main revenue sources being phosphoric acid (28.41%), feed-grade dicalcium phosphate (25.11%), and monoammonium phosphate (21.29%) [1]. - The company is located in the Qiannan Buyi and Miao Autonomous Prefecture of Guizhou Province and was established on November 25, 2002, with its shares listed on August 25, 2017 [1].
川恒股份1月16日获融资买入6622.67万元,融资余额4.76亿元